Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07563569

Determinants of Technical Success and Safety in Therapeutic ERCP for Obstructive Jaundice

compare the impact of type of anesthesia on ERCP including technical success, rate of complications, peri procedural safety, patient and endoscopist satisfaction in adult patients with obstructive jaundice

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Obstructive Jaundice Anesthesia Complication Anesthesia Effectiveness ERCP Hyperbilirubinemia Jaundice Jaundice, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms Skin Manifestations

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients above 18 years old.
  • Patient with obstructive jaundice as an indication for therapeutic ERCP.
  • Provided written informed consent.

Exclusion criteria

  • Patients below 18 years old.
  • Indications for ERCP other than obstructive jaundice.
  • with coagulopathy not corrected prior to procedure.
  • severe active cardiopulmonary comorbidities.
  • Previous altered upper GIT anatomy (e.g gastric by-pass).
  • Pregnancy

Treatment and study plan

ERCP

Procedure

Effect of anesthesia on Therapeutic ERCP in patients obstructive jaundice

Primary outcomes

  1. Impact of type of anesthesia on technical success rate

    Time frame: at the time of the procedure

    Technical success rate defined as successful deep biliary cannulation and completion of the intended therapeutic intervention.

Secondary outcomes

  1. rate of procedure related complications

    Time frame: at the time of procedure up to 72 hours post procedure

    Procedure related complication exclusively (post ERCP pancreatitis (based on revised Atlanta criteria), bleeding, perforation, cholangitis and aspiration pneumonia)

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed Khaled Abd El-Azeem

CONTACT

[email protected]

01066965222

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Determinants of Technical Success and Safety in Therapeutic ERCP for Obstructive Jaundice: A Prospective Comparative Study.

Acronym: ERCP

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
May 4, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.